Millennium’s CTO Michael Pavia says the company employs its homemade DNA chips to streamline just about every area of the drug discovery process.
By Peter Gwynne
Michael Pavia has a mission. He wants to cut the cost of bringing new drugs to market by 50 percent. As chief technology officer of Millennium Pharmaceuticals, he is well placed to do so.